Clotilde Allevena

17PUBLICATIONS
47CO-AUTHORS
Behavioural epidemiologyGene and molecular therapyMajor global burdens of diseaseNaturopathyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 15, 2026
Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study.

|Jul 14, 2026
Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort).

|Jun 17, 2026
Comparison of four frailty scores to predict adverse health events and mortality in people living with HIV aged 70 years and more (ANRS EP 66 SEPTAVIH study).

|May 22, 2026
Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study.

|Mar 06, 2026
Machine learning prediction of weight gain after antiretroviral therapy initiation in people with HIV: Insights from a large french real-world cohort.

Cyrielle Codde, Clément Benoist, Laurent Hocqueloux

|Nov 04, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.

Romain Palich, Jade Ghosn, Karine Lacombe

Pageof 3

Frequent Collaborators

4 joint publications

Isabelle Poizot-Martin

3 joint publications

Laurent Hocqueloux

3 joint publications

Olivier Chassany

3 joint publications

Martin Duracinsky